Dosimetry of 60/61/62/64Cu-ATSM: A hypoxia imaging agent for PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 7, 2005, Pages 764-770

  Laforest, Richard ^a   Dehdashti, Farrokh ^a   Lewis, Jason S ^a   Schwarz, Sally W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biodistribution; Hypoxia; Positron emission tomography; Radiation dosimetry

Indexed keywords

COPPER 62; COPPER 64; COPPER DIACETYLBIS(N 4 METHYLTHIOSEMICARBAZONE) CU 60; COPPER DIACETYLBIS(N 4 METHYLTHIOSEMICARBAZONE) CU 61; COPPER DIACETYLBIS(N 4 METHYLTHIOSEMICARBAZONE) CU 62; COPPER DIACETYLBIS(N 4 METHYLTHIOSEMICARBAZONE) CU 64; RADIOISOTOPE; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOSIMETRY; HUMAN; HYPOXIA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIATION ABSORPTION; RADIATION DOSE; RAT; TISSUE DISTRIBUTION; WHOLE BODY RADIATION;

ABSORPTION; AGED; ANIMALS; ANOXIA; CARCINOMA, NON-SMALL-CELL LUNG; COPPER; COPPER RADIOISOTOPES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOMETRY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 23744490884     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1756-x     Document Type: Article

References (25)

1. Crabtree HG, Cramer W. The action of radium on cancer cells I and II. Some factors determining the susceptibility of cancer cells to radium. Proc R Soc SerB 1933;113:238-50.
2. Brown JM. The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 1999;59:5863-70.
3. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-48.
4. Tannock I, Guttman P. Responses of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. Br J Cancer 1981;42:245-8.
5. Lewis JS, Welch MJ. PET Imaging of hypoxia. Q J Nucl Med 2001;45:183-8.
6. Koh W-J, Rasey JS, Evans ML. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 1992;22:199-212.
7. 18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996;36:417-28.
8. Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J Nucl Med 1997;38:1155-60.
9. 64Cu-ATSM in vivo and in vitro in a hypoxic tumor model. J Nucl Med 1999;40:177-83.
10. 4-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med 2001;42: 655-61.
11. 60Cu-ATSM. Eur J Nucl Med Mol Imaging 2003; 30:844-50.
12. 60Cu-ATSM: relationship to therapeutic response - a preliminary report. Int J Radiat Oncol Biol Phys 2003;55:1233-8.
13. 62Cu-PTSM. J Nucl Med 2000;41:309-14.
14. Fujibayashi Y, Matsumoto K, Yonekura Y, Konishi J, Yokoyama A. A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals. J Nucl Med 1989;30:1838-42.
15. 64Cu using a biomedical cyclotron. Nucl Med Biol 1997;24:35-43.
16. McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, et al. High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol 1999; 26:351-8.
17. National Nuclear Data Center, BrookHaven National Laboratory, http://www.nndc.bnl.gov/mird
18. Anderson CJ, Jones LA, Bass LA, Sherman EL, McCarthy DW, Cutler PD, et al. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor bearing rats. J Nucl Med 1998;39: 1944-51.
19. 3- octreotate in a somatostatin receptor-positive, tumor bearing rat model. Clin Cancer Res 1999;5:3608-16.
20. Lewis JS, Laforest R, Lewis MR, Anderson CJ. Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model. Cancer Biotherapy Radiopharm 2000;15:593-604.
21. Stabin MG. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37: 538-46.
22. Cutler PD, Schwarz SW, Anderson CJ, Connett JM, Welch MJ, Philpott GW, et al. Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso. J Nucl Med 1995;36:2363-71.
23. Recommendations of the International Commission on Radiological Protection, 1990.
24. 4- methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med 2000;14:323-8.
25. Fritzberg AR, Bloedow DC. Animal models in the study of hepatobiliary radiotracers. In: Lambrecht RM, Eckelman WC, editors. Animal models in radiotracer design. Berlin Heidelberg New York: Springer; 1983. p. 179-209.